La enfermedad inflamatoria intestinal (EII) es la inflamación crónica del tubo digestivo, que
comprende dos enfermedades claramente diferenciadas: la enfermedad de Crohn y la …

This is the first Latin American Consensus of the Pan American Crohn's and Colitis
Organisation (PANCCO) regarding special situations in patients with inflammatory bowel …

Adalimumab, a human monoclonal antibody to tumor necrosis factor alpha (TNF-α), was
initially approved for the treatment of moderate to severe rheumatoid arthritis in 2002. In the …

Tumour necrosis factor‐alpha antagonists for treatment of paediatric Crohn’s disease - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Human development of an individual from a fertilized ovum to maturity alters the body
anatomy and physiology. Changes of size and function, from birth onwards, cause …

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that has significant
morbidities in the pediatric population. Goals of medical therapy include induction and …

Introduction: Immune-mediated inflammatory disorders (IMIDs) are systemic conditions
which arise secondary to complex immune mechanism defects and can affect many organs …

Biologic targeted therapies in pediatric rheumatology × Close The Infona portal uses cookies,
ie strings of text saved by a browser on the user's device. The portal can access those files and …

A gyulladásos bélbetegség (IBD) a bélrendszer krónikus gyulladása, melynek hátterében
feltételezik a megváltozott bélflórára adott kóros autoimmun választ a szervezet részéről …

Adalimumab is a fully humanized anti-tumor necrosis factor alpha monoclonal antibody that
was recently granted regulatory approval in the USA for the treatment of moderate to severe …